Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SOFOSBUVIR Cause Diffuse large b-cell lymphoma recurrent? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with SOFOSBUVIR (Epclusa). This represents 0.0% of all adverse event reports for SOFOSBUVIR.

6
Reports of Diffuse large b-cell lymphoma recurrent with SOFOSBUVIR
0.0%
of all SOFOSBUVIR reports
2
Deaths
4
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma recurrent From SOFOSBUVIR?

Of the 6 reports, 2 (33.3%) resulted in death, 4 (66.7%) required hospitalization.

Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SOFOSBUVIR. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does SOFOSBUVIR Cause?

Fatigue (2,004) Drug ineffective (1,833) Hepatitis c (1,662) Headache (1,417) Nausea (1,211) Off label use (1,184) Anaemia (1,065) Insomnia (940) Hepatocellular carcinoma (877) Treatment failure (806)

What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?

RITUXIMAB (1,359) CYCLOPHOSPHAMIDE (1,007) VINCRISTINE (957) DOXORUBICIN (953) PREDNISONE (738) CYTARABINE (406) DEXAMETHASONE (402) ETOPOSIDE (375) CISPLATIN (306) GEMCITABINE (280)

Which SOFOSBUVIR Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?

SOFOSBUVIR vs SOFOSBUVIR\VELPATASVIR SOFOSBUVIR vs SOFOSBUVIR\VELPATASVIR\VOXILAPREVIR SOFOSBUVIR vs SOLIFENACIN SOFOSBUVIR vs SOLIRIS SOFOSBUVIR vs SOLOSTAR

Related Pages

SOFOSBUVIR Full Profile All Diffuse large b-cell lymphoma recurrent Reports All Drugs Causing Diffuse large b-cell lymphoma recurrent SOFOSBUVIR Demographics